Published October 2, 2017 | Version v1
Journal article

Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis

  • 1. Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Shiga (Japan)
  • 2. Department of Radiology, Shiga University of Medical Science, Otsu, Shiga (Japan)
  • 3. The Center for Data Science Education and Research, Shiga University, Hikone, Shiga (Japan)
  • 4. Department of Medical Statistics, Shiga University of Medical Science, Otsu, Shiga (Japan)
  • 5. Department of Radiology, Shiga University of Medical Science Hospital, Otsu, Shiga (Japan)
  • 6. Division of Infection Control and Prevention, Shiga University of Medical Science Hospital, Otsu, Shiga (Japan)
  • 7. Health Administration Center, Shiga University of Medical Science, Otsu, Shiga (Japan)

Description

The risk factors for radiation pneumonitis (RP) in patients with chronic obstructive pulmonary disease (COPD) are unclear. Mean lung dose (MLD) and percentage of irradiated lung volume are common predictors of RP, but the most accurate dosimetric parameter has not been established. We hypothesized that the total lung volume irradiated without emphysema would influence the onset of RP. We retrospectively evaluated 100 patients who received radiotherapy for lung cancer. RP was graded according to the Common Terminology Criteria for Adverse Events (version 4.03). We quantified low attenuation volume (LAV) using quantitative computed tomography analysis. The association between RP and traditional dosimetric parameters including MLD, volume of the lung receiving a dose of ≥2 Gy, ≥ 5 Gy, ≥ 10 Gy, ≥ 20 Gy, and ≥30 Gy, and counterpart measurements of the lung without LAV, were analyzed by logistic regression. We compared each dosimetric parameter for RP using multiple predictive performance measures including area under the receiver operating characteristic curve (AUC) and integrated discrimination improvement (IDI). Of 100 patients, RP of Grades 1, 2, 3, 4, and 5 was diagnosed in 24, 12, 13, 1, and 1 patients, respectively. Compared with traditional dosimetric parameters, counterpart measurements without LAV improved risk prediction of symptomatic RP. The ratio of the lung without LAV receiving ≥30 Gy to the total lung volume without LAV most accurately predicted symptomatic RP (AUC, 0.894; IDI, 0.064). Irradiated lung volume without LAV predicted RP more accurately than traditional dosimetric parameters. The online version of this article (10.1186/s13014-017-0891-z) contains supplementary material, which is available to authorized users.

Availability note (English)

Available from http://dx.doi.org/10.1186/s13014-017-0891-z; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625816

Additional details

Identifiers

Publishing Information

Journal Title
Radiation Oncology (Online)
Journal Volume
12
Journal Page Range
vp.
ISSN
1748-717X

Optional Information

Copyright
Copyright (c) The Author(s). 2017
Notes
PMCID: PMC5625816; PMID: 28969651; PUBLISHER-ID: 891; OAI: oai:pubmedcentral.nih.gov:5625816